EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Molecular landscape of CD8+ T cells in pure red cell aplasia

Yumei Liu, Mengyuan Liu, Xiaoman He, Liyan Yang, Mengying Zhang, Pu Tang, Limin Xing, Haiyue Niu, Huaquan Wang

Annals of Hematology · 2025-02 · 104 (2) · 953-961

DOI: 10.1007/s00277-025-06220-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Hematology, online erschienen am 31.01.2025. Verfasst von Yumei Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Tianjin Medical University General Hospital, No. 154 Anshandao Road, Heping District, Tianjin, 300052, China. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Red-Cell Aplasia, Pure. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Scientific Research Project of Tianjin Municipal Education Commission, Science and Technology Project of Tianjin Municipal Health Commission, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aberrant function of lymphocytes is considered a significant contributing factor to pure red cell aplasia (PRCA), but the precise mechanism by which T lymphocytes induce erythroid development stagnation remains unclear. In our study, the CD8+ T lymphocytes were isolated from bone marrow aspirates of acquired PRCA patients and healthy controls. RNA sequencing (RNA-Seq) was performed to analyze gene expression profiles. Additionally, the expression levels of key molecules and transcription factors were assessed at the transcription and protein levels. The RNA-Seq analysis revealed a significant upregulation of genes associated with the PI3K/AKT/mTOR pathway in CD8+ T lymphocytes from patients with PRCA, compared to healthy controls. The mRNA expression of AKT, mTOR and key transcription factors T-bet were significantly upregulated in CD8+ T cells from patients with PRCA. Treatment with rapamycin, an mTOR inhibitor, attenuated the activation of CD8+ T lymphocytes in PRCA patients. Our findings demonstrate the activation of the PI3K/AKT/mTOR signaling pathway in CD8+ T lymphocytes of PRCA patients, suggesting its involvement in PRCA pathogenesis. Targeting this pathway may offer a potential therapeutic strategy for PRCA characterized by CD8+ T cell dysregulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD8-Positive T-LymphocytesRed-Cell Aplasia, PureHumansMaleFemaleTOR Serine-Threonine KinasesMiddle AgedProto-Oncogene Proteins c-aktSignal TransductionAdultPhosphatidylinositol 3-KinasesAgedSirolimus

Stichwörter der Autor:innen

CD8Pure red cell aplasiaRNA sequencingT lymphocyte

Substanzen

TOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktMTOR protein, humanPhosphatidylinositol 3-KinasesSirolimus

Autor:innen und Institutionen

  • Department of Hematology, Tianjin Medical University General Hospital, No. 154 Anshandao Road, Heping District, Tianjin, 300052, China.
  • Tianjin Key Laboratory of Bone Marrow Failure and Malignant Hemopoietic Clone Control, Tianjin, 300052, China.
  • Tianjin Institute of Hematology, Tianjin, 300052, China.
  • Department of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China. niuhaiyue@tmu.edu.cn.
  • Department of Hematology, Tianjin Medical University General Hospital, No. 154 Anshandao Road, Heping District, Tianjin, 300052, China. wanghuaquan@tmu.edu.cn.
  • Tianjin Key Laboratory of Bone Marrow Failure and Malignant Hemopoietic Clone Control, Tianjin, 300052, China. wanghuaquan@tmu.edu.cn.

Förderung

  • Scientific Research Project of Tianjin Municipal Education Commission
  • Science and Technology Project of Tianjin Municipal Health Commission
  • National Natural Science Foundation of China
  • Key Technology Research and Development Program of Tianjin China
  • Tianjin Key Medical Discipline (Specialty) Construction Project

Zitieren

APA

Liu, Y., Liu, M., He, X., Yang, L., Zhang, M., Tang, P., Xing, L., Niu, H., & Wang, H. (2025). Molecular landscape of CD8+ T cells in pure red cell aplasia. Annals of Hematology, 104(2), 953-961. https://doi.org/10.1007/s00277-025-06220-5

Vancouver

Liu Y, Liu M, He X, Yang L, Zhang M, Tang P, et al. Molecular landscape of CD8+ T cells in pure red cell aplasia. Annals of Hematology. 2025;104(2):953-961. doi:10.1007/s00277-025-06220-5

BibTeX
@article{Liu2025,
  author = {Liu, Yumei and Liu, Mengyuan and He, Xiaoman and Yang, Liyan and Zhang, Mengying and Tang, Pu and Xing, Limin and Niu, Haiyue and Wang, Huaquan},
  title = {Molecular landscape of CD8+ T cells in pure red cell aplasia},
  journal = {Annals of Hematology},
  year = {2025},
  volume = {104},
  number = {2},
  pages = {953--961},
  doi = {10.1007/s00277-025-06220-5}
}
Kostenlos starten →